Navigation Links
LifeSync Purchases Wireless Patent Portfolio from Motorola
Date:12/22/2009

FORT LAUDERDALE, Fla., Dec. 22 /PRNewswire/ -- LifeSync Holdings, Inc. is pleased to announce that it has purchased the Besson Patent Portfolio and other wireless vital sign patents from Motorola, Inc. The Besson Patents describe the use of wireless, two-way, digital communication between patient-electrodes or sensors and an evaluator station for monitoring a patient. The acquired patent portfolio includes additional wireless improvements including a wireless system telemetry protocol and programmable wireless electrode systems for medical monitoring. "We are excited about the opportunities for growth in our licensing program that these key assets will provide," said Shelley Hartman, President and CEO of LifeSync. Terms were not disclosed.

About LifeSync Holdings, Inc.

LifeSync Holdings, Inc. is the parent company of LifeSync Corporation, the manufacturer and distributor of the LifeSync Wireless ECG System. This system is a wireless ECG transmission device used by hospitals in conjunction with their existing patient monitoring equipment to improve patient safety and hospital productivity. Please visit our website at www.LifeSyncCorp.com for more information or contact us at 954-745-3510.

SOURCE LifeSync Holdings, Inc.


'/>"/>
SOURCE LifeSync Holdings, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Despite Limited Capital Equipment Purchases In 2009, The Global Powered Surgical Instrument Market Held Its Value At $800 Million
2. Paul Capital Healthcare Purchases Additional Royalty Interest in GlaxoSmithKlines Rotarix(R)
3. Triage Wireless, Inc. Becomes Sotera Wireless, Inc.
4. Verizon Wireless Offers Home Health Care Industry Custom Mobile Application To Be More Productive
5. Atlanta-based Med Tech Company CardioMEMS Raises Additional Capital to Advance its CHAMPION Clinical Trial for its Wireless Sensor System for Heart Failure Monitoring
6. West Wireless Health Institute Teams with Corventis for its First Multicenter, Randomized Clinical Trial
7. Amgen Resolves EPO Patent Dispute With Roche
8. Mylan Confirms First-to-File Patent Challenge Relating to Vytorin(R) Cholesterol Medication
9. Hologic Announces Decision in Patent Infringement Suit
10. Savara Closes Second Tranche of Series A Financing Round, Receives Allowance for Base Patent
11. SRI International Receives U.S. Patent for Needle-Free Transmucosal Drug Delivery System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2017)... Oct. 2, 2017  AllianceRx Walgreens Prime, the combined ... Walgreens and pharmacy benefit manager Prime Therapeutics LLC (Prime), ... which included the unveiling of new signage at its ... well as at a few other company-owned facilities across ... to patients, some of whom will begin to see ...
(Date:9/28/2017)... Sept. 28, 2017 Hill-Rom Holdings, Inc. (NYSE: ... conference call and webcast on Friday, November 3, 2017, ... and ending at approximately 8:30 a.m. (CDT) / 9:30 ... company,s 2017 financial performance and guidance for 2018, Hill-Rom ... to enhance operational performance, and long-range financial outlook through ...
(Date:9/27/2017)... and NEW YORK , Sept. 27, 2017  DarioHealth ... and big data solutions, today announced that its MyDario product is expected ... local TV listings for when The Dr. Oz Show airs in your ... The nine-time Emmy ... ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... ... “America On The Brink”: the Christian history of the United States and ... of published author, William Nowers. Captain Nowers and his wife, Millie, have six ... years in the Navy. Following his career as a naval aviator and carrier ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 ... characterized by frequent cessation in breathing. Oral appliances can offer significant relief to ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... the demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults ... tested to meet the highest standard. , These products are also: Gluten ...
(Date:10/12/2017)... ... ... The American College of Medical Informatics (ACMI) will present the 2017 Morris ... of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium is taking ... in the field of medical informatics, this prestigious award is presented to an individual ...
(Date:10/12/2017)... ... 12, 2017 , ... Information about the technology: , Otomagnetics ... enable prevention of a major side effect of chemotherapy in children. Cisplatin and ... For cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. ...
Breaking Medicine News(10 mins):